ACI

Albertsons Companies
NYSECONSUMER DEFENSIVEGROCERY STORES

Key Statistics

Market Cap
$6.38B
P/E Ratio
—
EPS
$-0.02
Beta
0.23
52W High
$19.18
52W Low
$10.86
50-Day MA
$12.20
200-Day MA
$15.15
Dividend Yield
4.89%
Profit Margin
-0.06%
Forward P/E
6.09
PEG Ratio
1.22

About Albertsons Companies

Albertsons Companies, Inc. participates in the pharmacy and food operation in the United States.

Official WebsiteUSAFY End: February

Fundamentals

Revenue (TTM)$83.21B
Gross Profit (TTM)$22.46B
EBITDA$3.44B
Operating Margin1.52%
Return on Equity-2.27%
Return on Assets3.66%
Revenue/Share (TTM)$164.18
Book Value$2.96
Price-to-Book3.52
Price-to-Sales (TTM)0.08
EV/Revenue0.253
EV/EBITDA6.49
Quarterly Earnings Growth (YoY)-64.60%
Quarterly Revenue Growth (YoY)-0.10%
Shares Outstanding$489.78M
Float$324.36M
% Insiders1.20%
% Institutions96.63%

Historical Volatility

HV 10-Day
34.38%
HV 20-Day
31.91%
HV 30-Day
35.13%
HV 60-Day
33.90%
HV Rank
66.7%

Volatility is currently contracting

Analyst Ratings

Consensus ($14.06 target)
2
Strong Buy
4
Buy
11
Hold
1
Sell
1
Strong Sell

Latest News

Longleaf Partners Global Fund Q3 2026 Portfolio Review

Biopharma company Regeneron reported a solid set of results, with key drug Dupixent continuing to outpace our and the market's growth expectations. In the first part of the year before we invested, Abbott slightly missed earnings estimates while it was digesting its acquisition of Exact Sciences, along with a variety of turmoil in the medtech and infant nutrition industries. Digital and print publisher People Inc. was a detractor in the quarter, while hospitality and entertainment company MGM Resorts also detracted.

Seeking Alpha10/14/2026Neutral
Albertsons Is Betting on a Turnaround—But Will It Pay Off?

Albertsons Companies TodayACIAlbertsons Companies$12.75 +0.21 (+1.65%) As of 10/13/2026 03:59 PM Eastern This is a fair market value price provided by Massive. Learn more.52-Week Range$10.86▼$20.00Dividend Yield5.33%P/E Ratio159.34Price Target$14.62Add to WatchlistAlbertsons Companies NYSE: ACI stock showed signs of bottoming in mid-October, rising by more than 2% following its Q2 fiscal year 2027 (FY2027) earnings report.

MarketBeat10/14/2026Positive
Longleaf Partners Fund Q3 2026 Portfolio Review

The market is regaining confidence in Avantor's ability to grow organically and in Emmanuel Ligner's turnaround plan. Biopharma company Regeneron reported a solid set of results, with key drug Dupixent continuing to outpace our and the market's growth expectations. Building products company Fortune Brands Innovations saw its stock price decline in Q3, retracing Q2's positive move related to excitement over Jesse Singh's appointment as CEO.

Seeking Alpha10/14/2026Neutral
Albertsons Companies Q2 Earnings Call Highlights

Albertsons Companies NYSE: ACI reported a 0.8% decline in second-quarter identical sales and outlined a broader turnaround effort centered on cost reductions, targeted price investments, operational simplification and a review of its portfolio of businesses and assets.

MarketBeat10/13/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ACI and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More CONSUMER DEFENSIVE Stocks

Data last updated: 10/17/2026